Daiichi Sankyo France
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer (NCT05149014) | Daiichi Sankyo France | 2021-12-14 |
Track Daiichi Sankyo France automatically
Every clearance here is in the API, with alerts when new ones post.